Non-invasive diagnosis of graft rejection in organ transplant patients
AssigneeThe Board of Trustees of the Leland Stanford Junior University
InventorsStephen R. Quake, Thomas M. Snyder, Hannah Valantine
Life of this patent
Estimating the term…
Abstract
The invention provides methods, devices, compositions and kits for diagnosing or predicting transplant status or outcome in a subject who has received a transplant.
Drawings
Claims29
A method of detecting solid organ transplant derived cell-free nucleic acids in a recipient that has received a solid organ transplant, the method comprising:
- a. genotyping said recipient to obtain a single nucleotide polymorphism (SNP) profile of said recipient, wherein said SNP profile of said recipient comprises SNPs for which said recipient is homozygous or heterozygous;
- b. providing nucleic acids from a biological sample from said recipient after said recipient has received said solid organ transplant, wherein said biological sample is selected from said group consisting of blood, serum and plasma, and wherein said nucleic acids from said biological sample comprise cell-free nucleic acids from said solid organ transplant and from said recipient;
- c. performing a high-throughput sequencing reaction on said nucleic acids from said biological sample from said recipient to obtain nucleic acid sequence data;
- and
- d. determining an amount of solid organ transplant derived cell-free nucleic acids from said solid organ transplant, wherein said amount of solid organ transplant derived cell-free nucleic acids is determined by detecting a plurality of nucleic acid sequences from said nucleic acid sequence data that differ from said SNP profile of said recipient.
Dependencies are inferred from the claim text.